Triple
T4689746
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ATC |
E104004
|
entity |
| Predicate | updatedBy |
P1121
|
FINISHED |
| Object | WHO Collaborating Centre for Drug Statistics Methodology |
E462928
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: WHO Collaborating Centre for Drug Statistics Methodology | Statement: [ATC, updatedBy, WHO Collaborating Centre for Drug Statistics Methodology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: WHO Collaborating Centre for Drug Statistics Methodology Context triple: [ATC, updatedBy, WHO Collaborating Centre for Drug Statistics Methodology]
-
A.
WHO Collaborating Centre for Drug Statistics Methodology
chosen
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
B.
European Monitoring Centre for Drugs and Drug Addiction
The European Monitoring Centre for Drugs and Drug Addiction is an EU agency that provides independent, evidence-based analysis on drugs, drug use, and related consequences to support policymaking in Europe.
-
C.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
D.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
E.
STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43df91f481908e9add1b617b60ef |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd6399621881909aa8ffb1c27284e9 |
completed | March 20, 2026, 3:11 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69be105a709c819083504fe1dc1612d8 |
completed | March 21, 2026, 3:28 a.m. |
Created at: March 20, 2026, 1:16 p.m.